Frontiers | The magic bullet: Niclosamide
Niclosamide causes lysosome-dependent cell death in endometrial cancer cells and tumors. - ScienceDirect
Niclosamide, STAT3 inhibitor (CAS 50-65-7) (ab120868) | Abcam
Frontiers | Niclosamide Induces Cell Cycle Arrest in G1 Phase in Head and Neck Squamous Cell Carcinoma Through Let-7d/CDC34 Axis
Frontiers | Drug Repurposing: The Anthelmintics Niclosamide and Nitazoxanide Are Potent TMEM16A Antagonists That Fully Bronchodilate Airways
Using Salt Cocrystals to Improve the Solubility of Niclosamide | Crystal Growth & Design
Frontiers | The magic bullet: Niclosamide
Frontiers | Drug Repurposing of the Anthelmintic Niclosamide to Treat Multidrug-Resistant Leukemia
StudyPages - Enzalutamide and Niclosamide in Treating Patients With Recurrent or Metastatic Castration-Resistant Prostate Cancer
Niclosamide | CAS 50-65-7 - Order from Adipochem
In Vitro Evaluation and Mitigation of Niclosamide's Liabilities as a COVID-19 Treatment | bioRxiv
Pharmaceutical Cocrystals of Niclosamide | Crystal Growth & Design
Frontiers | Niclosamide does not modulate airway epithelial function through blocking of the calcium activated chloride channel, TMEM16A
Migration and Transformation Characteristics of Niclosamide in a Soil–Plant System | ACS Omega
In Vitro Evaluation and Mitigation of Niclosamide's Liabilities as a COVID-19 Treatment | bioRxiv
Frontiers | Computational Screening Strategy for Drug Repurposing Identified Niclosamide as Inhibitor of Vascular Calcification
Niclosamide Exposure at Environmentally Relevant Concentrations Efficaciously Inhibited the Growth and Disturbed the Liver-Gut Axis of Adult Male Zebrafish | Environmental Science & Technology
Vaccines | Free Full-Text | In Vitro Evaluation and Mitigation of Niclosamide’s Liabilities as a COVID-19 Treatment
Discovery of O-Alkylamino-Tethered Niclosamide Derivatives as Potent and Orally Bioavailable Anticancer Agents | ACS Medicinal Chemistry Letters
Vaccines | Free Full-Text | In Vitro Evaluation and Mitigation of Niclosamide’s Liabilities as a COVID-19 Treatment
Benzimidazole inhibitors from the Niclosamide chemotype inhibit Wnt/β-catenin signaling with selectivity over effects on ATP homeostasis - ScienceDirect
Pharmaceutical Cocrystals of Niclosamide | Crystal Growth & Design
